Cochrane COVID-19 Study Register
Study record
NCT04920357First Published: 2021 Jun 10Updated Date: 2021 Jun 10

CoVacc - Immune Response to Vaccination Against Covid-19, an Open Multicenter Phase IV Study

  1. Study Type
  2. Observational
  1. Study Aim
  2. Prevention
  1. Study Design
  2. Case series/Case control/Cohort
  1. Intervention Assignment
  2. Not Applicable
Reference record

Immune Response to Vaccination Against Covid-19, a Follow up Study

Umea University
First Published (first received 2021 June 09)ClinicalTrials.gov (https://clinicaltrials.gov/show/NCT04920357)
Trial registry record
No Results
The study investigates the immune response after vaccination in individuals with and without pre-existing immunity to Coronavirus disease (COVID) -19. The participants are followed and sampled up to 4 years after vaccination. Blood samples are collected at different timepoints to analyze immune response. The aim is to investigate the level of specific antibodies to Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) yearly, up to 4 years after vaccination